Moneycontrol PRO
you are here: HomeNewsOpinion

India should make a strategic investment in vaccine manufacturers

Despite the current hype, vaccines aren’t a hugely profitable area of pharmaceuticals 

April 15, 2021 / 08:30 AM IST
India should make a strategic investment in vaccine manufacturers

The outlook for the emerging market is uncertain, partly due to a large population base and low availability of vaccines. (File Image)

Adar Poonawalla,​ the chief executive officer of Serum Institute of India (SII), has said his company needs Rs 3000 crore to ramp up its vaccine manufacturing capacity at this critical juncture. While it is not known if Krishna Ella, chairman of Bharat Biotech Ltd. (BBL), the other major vaccine producer in the country, has expressed similar views, it is safe to assume that the Hyderabad-based manufacturer too could use the extra funding. Nor is it an unusual request. Many...

  • PRO Panorama

    Moneycontrol Pro Panorama | Robinhood missed the mark on a bumper listing

    Jul 30, 2021 / 04:26 PM IST

    In today’s edition of Moneycontrol Pro Panorama:  Why Robinhood stumbled, the problem with IMF forecasts, the Immunity Tracker, Tech Mahindra’s growth appeal, Tactical Pick, the Indian startup rage, China pushes back on crypto and more  

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers